MITCHELL MUTZ

Profile

First Name

: MITCHELL

Middle Name

:

Last Name

: MUTZ

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
AMPLYX PHARMACEUTICALS, INC.
JACK FLORIO, ALAN FUHRMAN, MICHAEL GREY, PAUL GRINT, ELAINE HERON, MIKE HODGES, JOHAN K?RDEL, CIARA KENNEDY, JOHAN KORDEL, ED MATHERS, EDWARD MATHERS, ANAND MEHRA, CHRYSA MINEO, NIALL ODONNELL, KAREN TALMADGE, SANTOSH VETTICADEN
DIRECTOR
PURIGEN BIOSYSTEMS, INC.
MIRA CHAURUSHIYA, PH.D., BILL W. COLSTON, BILL W. COLSTON, PH.D., KEVIN CORCORAN, AMY HIDDESSEN, STEVE REICHENBACH, KLINT ROSE, KLINT ROSE, PH.D., JUAN SANTIAGO, JUAN G. SANTIAGO, BARNETT SAUNDERS, BARNEY E. SAUNDERS,PH.D., ANDREW SCHWAB, JOSEPH VICTOR, JOSEPH J. VICTOR
DIRECTOR
PANDION THERAPEUTICS, INC.
ANTHONY COYLE, ALAN CRANE, VIKAS GOYAL, CARLO RIZZUTO, JO VINEY
DIRECTOR
GOOD THERAPEUTICS, INC.
KARL HANDELSMAN, DIANE HOLLENBAUGH, JOHN MCKEARN, JOHN MULLIGAN, NEELA PATEL, MONIQUE SCHIERSING, NICHOLAS WALROD
DIRECTOR
PANDION THERAPEUTICS HOLDCO LLC
DANIEL BECKER, JILL CARROLL, ALAN L. CRANE, DONALD FRAIL, CHRISTOPHER FUGLESANG, VIKAS GOYAL, RAHUL KAKKAR, CARLO RIZZUTO, NANCY STAGLIANO, JO VINEY
DIRECTOR
BONUM THERAPEUTICS, INC.
GAURAV AGGARWAL, SAMUEL BJORK, SAMUEL BLACKMAN, KARL HANDELSMAN, DIANE HOLLENBAUGH, JOHN MCKEARN, JOHN MULLIGAN, NEELA PATEL, MONIQUE SCHIERSING, NICHOLAS WALROD
EXECUTIVE OFFICER, DIRECTOR
EPIBIOLOGICS, INC.
SAMUEL BJORK, ALEXANDRA CANTLEY, JASON COLOMA, RAMI HANNOUSH, MICHAEL KAVANAUGH, ANN LEE-KARLON, CRAIG LICHTENSTEIN, SEIJI MIYAHARA, JAMES WELLS
DIRECTOR
OMNIOX, INC.
STEPHEN CARY, LAURENCE MARTON, JEFF SAMBERG, JEFFREY S. SAMBERG, AJIT SHAH, JOHN WESLEY, JONATHAN WINGER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2026-04-03 
2026-03-30
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-01 
2024-04-25
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-21 
2023-04-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-03-21 
2022-11-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-15 
2020-05-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
2020-04-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-23 
2019-02-08
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
2018-11-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-09 
2018-06-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-04 
2018-01-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-05 
2017-10-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-03-04 
2015-12-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-29 
2015-11-12
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-29 
2015-08-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2015-08-11